Status:
UNKNOWN
SWIDINEP a Swiss Diabetic Nephropathy Cohort
Lead Sponsor:
Centre Hospitalier Universitaire Vaudois
Conditions:
Diabetic Nephropathy
Eligibility:
All Genders
18+ years
Brief Summary
With our SWIDINEP cohort, we propose to explore the relationship between vascular risk markers and renal function decline in CKD stage 1-5. In order to realize these goals, we intend to recruit 200 pa...
Detailed Description
Serum, plasma, and fresh urine samples as well as whole blood (buffy coat for DNA extraction and genotyping) are stored at -80°C in a local biobank according to the latest guidelines of the Académie S...
Eligibility Criteria
Inclusion
- Type 2 diabetes
- eGFR \<60ml/min or albumine/creatinine ratio \>3mg/mmol
- Can understand french and has signed the consent form.
Exclusion
- Age \< 18y
- Another cause of nephropathy (excluding hypertensive nephropathy, obese related nephropathy)
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03407989
Start Date
January 1 2014
End Date
January 1 2022
Last Update
August 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire Vaudois
Lausanne, Canton of Vaud, Switzerland, 1011